Evolution of new enzymatic activities is believed to require a period of gene sharing in which a single enzyme must serve both its original function and a new function that has become advantageous to the organism. Subsequent gene duplication allows one copy to maintain the original function, while the other diverges to optimize the new function. The physiological impact of gene sharing and the constraints imposed by the need to maintain the original activity during the early stages of evolution of a new activity have not been addressed experimentally. We report here an investigation of the evolution of a new activity under circumstances in which both the original and the new activity are critical for growth. Glutamylphosphate reductase (ProA) has a very low promiscuous activity with N-acetylglutamylphosphate, the normal substrate for ArgC (N-acetylglutamylphosphate reductase). A mutation that changes Glu-383 to Ala increases the promiscuous activity by 12-fold but decreases the original activity by 2,800-fold. The impairment in Pro and Arg synthesis results in 14-fold overexpression of E383A ProA, providing sufficient N-acetylglutamylphosphate reductase activity to allow a strain lacking ArgC to grow on glucose. Thus, reaching the threshold level of NAGP reductase activity required for survival required both a structural mutation and overexpression of the enzyme. Notably, overexpression does not require a mutation in the regulatory region of the protein; amino acid limitation attributable to the poor catalytic abilities of E383A ProA causes a physiological response that results in overexpression.
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catalytic promiscuity ͉ molecular evolution ͉ ProA ͉ recruitment O ver billions of years, divergent evolution has generated large mechanistically diverse superfamilies via gene duplication and elaboration of an ancestral scaffold, usually with retention of some of the catalytic abilities of the ancestral enzyme. Examples include the enolase (1), haloacid dehalogenase (2) , and amidohydrolase superfamilies (3) , in which the retained ancestral activity is abstraction of a proton alpha to a carboxylate, ester hydrolysis, and activation of water for nucleophilic attack, respectively. Emergence of new activities from an ancestral scaffold requires alterations of active site residues to allow catalysis of new chemical steps and to optimize binding of new substrates.
The relative timing of the gene duplication and mutations that result in emergence of a new activity has been debated for decades (4) . In 1970, Ohno (5) suggested that gene duplication allows one copy of a gene to accumulate mutations required for emergence of a new activity, while the other continues to provide the original function. This idea is appealing because the function of the original protein can be preserved while a paralog evolves. However, a problem with this hypothesis is that mutations are far more likely to destroy the function of a protein than to create a new function. In some cases, gene duplication results in subfunctionalization, a division of the properties of the original protein between the proteins encoded by the two copies of the gene (6). However, neofunctionalization (evolution of new properties) is likely to be rare. Based on this reasoning, Hughes (7) proposed in 1994 that new enzymes emerge by mutations that generate a new activity before gene duplication. Such activities would be considered ''promiscuous activities.'' Promiscuous activities serve no particular function in the organism, and thus are not subject to selection (8) . Promiscuous activities are generally orders of magnitude less efficient than well-evolved activities (9-12), but they may enhance reaction rates by orders of magnitude relative to uncatalyzed reactions (11, 12) . If the environment changes, a promiscuous activity may be recruited to serve a new function that enhances fitness, providing the scenario envisioned by Hughes in which selective pressure to retain a gene copy will exist immediately upon duplication. This hypothesis predicts that a period of gene sharing before gene duplication is generally required for emergence of a new enzymatic activity.
The implications of gene sharing during the early stages of evolution of a new enzymatic activity have received little attention. We expect that the evolutionary trajectory for emergence of a new activity before gene duplication might be constrained by the need to maintain the original function of the protein. However, the degree of constraint should be a function of many parameters, reflecting the importance of the original and new activities for fitness. A particularly critical issue is how mutations that enhance a new activity affect the original activity. Given that most active sites have been honed to align the substrate optimally with respect to catalytic groups, mutations that enhance a promiscuous activity might be expected to compromise the original activity. This supposition is supported by many examples of enhancements in promiscuous activities achieved by sitedirected mutagenesis (13) (14) (15) and in vitro evolution (16) . For example, a point mutation in alanine racemase decreases the original activity by 4 ϫ 10 3 , while increasing a promiscuous aldolase activity by 2.3 ϫ 10 5 (14) . Surprisingly, however, this is not always true. Khersonsky et al. (17) review 11 cases in which substantial increases in a promiscuous activity (10-to 10 6 -fold) were achieved by mutations that caused only a small decrease in the original activity (Ͻ42-fold). Similarly, Rothman and Kirsch (18) evolved a broad-specificity transaminase from an aspartate transaminase that retained its original activity with aspartate, while acquiring substantial activity with phenylalanine and tyrosine. The idea that a new activity can emerge without significantly compromising the original activity is appealing, because it provides ''something for nothing.'' Such cases might seem to be especially promising for evolution of a new activity. It is not yet clear whether there are particular structural and mechanistic features that permit acquisition of new activities without substantial compromise of the original function. It is also not clear that evolution of new activities must proceed only along pathways in which there are only weak trade-offs between the original and new activities.
Most explorations of the effects of mutations on promiscuous and original functions of enzymes have involved site-directed mutagenesis or directed evolution experiments in which the original activity, and sometimes the promiscuous activity as well, is irrelevant to the fitness of the bacterium. No studies have been carried out under conditions in which both activities are required for growth. Here, we examine the consequences of gene sharing during emergence of a new catalytic activity under conditions in which both the original activity and the new activity of the enzyme are required for growth. N-acetylglutamylphosphate (NAGP) reductase (ArgC) (Fig. 1) catalyzes conversion of NAGP to N-acetylglutamate 5-semialdehyde (NAGSA) in the pathway for synthesis of arginine (Arg). Cells lacking argC cannot grow on glucose as a sole carbon source. A mutation in proA, which encodes glutamylphosphate (GP) reductase, moderately enhances a promiscuous NAGP reductase activity but substantially damages the original GP reductase activity. Overexpression of the enzyme triggered by the cells' impaired ability to synthesize Pro and Arg results in sufficient levels of both activities to support growth on glucose. The importance of compensatory changes resulting from damage to the original activity of an enzyme, as well as global responses to the poor function of a newly evolving enzyme, have not been previously appreciated.
The situation we have explored is artificial in the sense that we created a requirement for a new activity by knocking out a critical metabolic gene. However, it is a reasonable mimic of situations that might occur in nature when a new enzymatic activity is critical to modify a toxin or exploit a novel source of carbon or nitrogen in a nutrient-limited environment. Although mutations enhancing a promiscuous activity in a nonessential gene might seem to be the optimal way to evolve a new enzyme, that option may not always exist. Our results demonstrate that even a mutation that compromises a critical biosynthetic pathway may be tolerated if it allows survival and provides a selective advantage over other microbes that are also struggling under novel environmental conditions.
Results
Generation of Pseudorevertants of Escherichia coli ⌬argC::kan that Grow on Glucose. We treated an ⌬argC::kan strain from the Keio collection (19) with N-methyl-NЈ-nitro-N-nitrosoguanidine (MNNG) and obtained pseudorevertants on plates containing M9/glucose supplemented with proteinogenic amino acids other than Arg, vitamins, and nucleobases (added in case mutations caused by MNNG interfered with essential biosynthetic pathways). However, the pseudorevertants grew on glucose without supplementation as well. One of the larger colonies (PR1) was selected for further analysis.
The ability of PR1 to grow on glucose could be due to a mutation that (i) increases the level of a promiscuous NAGP reductase activity in another enzyme, (ii) increases expression of an enzyme with promiscuous NAGP reductase activity, or (iii) facilitates a bypass pathway that allows Arg synthesis via a novel route. To differentiate between complementation by a promiscuous enzyme and a bypass pathway, we measured ArgC activity in crude extracts of PR1. Because of the instability of NAGP, we assay the enzyme in the reverse direction using NAGSA and NADP ϩ as substrates (20) . The Haldane relationship (Eq. 1) (21) shows that the equilibrium constant is defined by the ratio of the rate constants for the forward and reverse reactions. Because a catalyst does not change K eq , the fold-change in the rate constant for the reverse reaction attributable to a mutation is equal to that in the rate constant for the forward reaction. NAGSA dehydrogenase activity in a crude extract of PR1 (1.68 nmol⅐min Ϫ1 ⅐mg Ϫ1 ) was 56-fold higher than that in a crude extract from the parental ⌬argC::kan strain (0.03 nmol⅐min Ϫ1 ⅐mg Ϫ1 ). (Both strains were grown on M9/glucose plus Arg because the parental strain cannot grow on glucose alone.)
Purification and Identification of the Enzyme with Promiscuous ArgC
Activity. The protein responsible for NAGSA dehydrogenase activity in PR1 was partially purified by three chromatographic steps. Two major bands obtained by SDS/PAGE of the final fraction were digested with trypsin and identified by mass spectrometry. One band was identified as GP reductase (ProA) based upon matches between four observed and predicted fragments (E-values between 0.012 and 3.7 ϫ 10 Ϫ8 ). The other was identified as glyceraldehyde-3-phosphate dehydrogenase (GapA) based upon matches between 18 observed and predicted fragments (E-values between 0.044 and 3.7 ϫ 10 Ϫ10 ). Glutamylphosphate reductase (ProA) catalyzes conversion of GP to glutamate semialdehyde (GSA) in the Pro synthesis pathway ( Fig. 1) , and GapA catalyzes conversion of glyceraldehyde 3-phosphate to 1,3-diphosphoglycerate in the glycolytic pathway.
The proBA operon (proA is transcribed as part of an operon with proB, which encodes ␥-glutamyl kinase) and gapA were amplified from PR1 genomic DNA and sequenced. Both proA and gapA had mutations. A t-to-c transition in gapA results in replacement of Ser-207 with Phe. An a-to-c transversion in proA results in replacement of Glu-383 with Ala. In addition, the promoter of the proBA operon had a c-to-t transition at the Ϫ5 position, which makes the Ϫ10 region more similar to the Escherichia coli consensus sequence (22) . We cloned both mutant genes into pTrcHisB (Invitrogen), expressed the His 6 -tagged proteins in the ⌬argC::kan strain (to avoid contamination with WT ArgC), and purified the proteins to homogeneity by nickel affinity chromatography. Only E383A ProA had significant NAGSA dehydrogenase activity.
Confirmation that the Mutant proA Was Responsible for Restoration
of Growth on Glucose in PR1. We confirmed that proA was responsible for restoring growth of PR1 on glucose by deleting it using the method of Datsenko and Wanner (23) . The ⌬argC::kan ⌬proA::cat strain was unable to grow on M9/glucose. Further confirmation was provided by introduction of a library of PR1 DNA into the ⌬argC::kan strain. Plasmids isolated from three colonies that grew on glucose all carried the mutant proBA operon.
Definition of the Evolutionary Trajectory for Accumulation of the Two
Mutations Affecting proA in PR1. The observance of two mutations in proBA in PR1 begs the question of whether one mutation must occur first. Insight into the likelihood of the two evolutionary trajectories in Fig. 2 is provided by analysis of 2 other pseudorevertants obtained from the initial experiment and 21 pseudorevertants obtained from a second experiment. Every pseudorevertant had the mutation in proA that changes Glu-383 to Ala. Twenty-one had no promoter mutations. One had a c-to-t transition at Ϫ5 relative to the transcription start site, and another had a g-to-t transversion at Ϫ30. These results suggest that the structural mutation occurs first. However, the phenotypes of these strains might have been affected by other mutations caused by MNNG. Consequently, we explored the effect of the two mutations, alone and in combination, upon the growth of the ⌬argC::kan ⌬proA::cat strain, which had not been treated with MNNG. We cloned WT proBA and versions containing the promoter mutation, the structural mutation, or both, into the single-copy vector pBeloBACII, and introduced these plasmids into the ⌬argC::kan ⌬proA::cat strain. By providing a single copy of each gene under control of its own promoter, this experiment recapitulates a situation in which point mutations occur in the promoter or structural region of a single chromosomal copy of a gene. The promoter mutation does not allow growth on glucose ( Fig. 3 A and B) . The structural mutation allows slow growth. Growth is substantially improved when both mutations are present, although it is, as expected, slower than growth of the ⌬argC::kan ⌬proA::cat strain expressing WT ProA on glucose supplemented with Pro and Arg. We conclude that the evolutionary trajectory requires the structural mutation first, followed by the promoter mutation.
Characterization of E383A ProA. The activities of WT and E383A ProA were assayed with both NAGSA and GSA ( Table 1) . Comparison of k cat /K M for NAGSA and GSA shows that the promiscuous NAGSA dehydrogenase activity of WT ProA is nearly five orders of magnitude less efficient than the normal GSA dehydrogenase activity. E383A ProA has 12-fold higher NAGSA dehydrogenase activity but 2800-fold less GP reductase activity than WT ProA. Thus, generation of a very modest NAGP reductase activity comes at a steep price with respect to the normal GP reductase activity.
Glu-383 of ProA is located near the active site. In the Thermotoga maritima ProA (24), the side chain of the corresponding Glu-381 is 8 Å away from the catalytic cysteine and protrudes into a cleft between two domains. Replacement of Glu-383 with Ala removes both steric bulk and a negative charge. We suspected that this might allow NAGP, which is larger than GP and lacks a positive charge on the nitrogen, to bind to the active site. However, binding constants for NAGSA and GSA were not affected by the E383A change (Table 1) . More detailed kinetic and structural analyses will be required to elucidate the reason for the improved NAGSA dehydrogenase activity of E383A ProA.
Analysis of the Levels of Expression of WT and E383A ProA. The ability of cells to grow when both NAGP and GP reductase activities are supplied by a single and notably poor enzyme is intriguing. We wondered whether overexpression of E383A ProA might partially compensate for its poor activities. We analyzed levels of ProA in the ⌬argC::kan ⌬proA::cat strain carrying WT proBA and versions containing the promoter mutation, the structural mutation, or both, in pBeloBACII (Fig. 4) . The His 6 -tag at the C-terminal end of ProA was detected using Penta-His antibody (Qiagen). When cells were grown in M9/glucose supplemented with Pro and Arg, conditions under which neither activity of ProA is required, expression of ProA (WT or E383A) was increased 4-fold by the promoter mutation. However, when cells were grown in M9/glucose supplemented with Arg, conditions under which GP reductase is required for growth, E383A ProA was overexpressed 6-fold from the normal promoter. These data suggest that the poor activity of E383A ProA results in upregulation of proBA, either because of a specific increase in transcription of proBA due to low Pro levels or a global response to amino acid limitation. To test this possibility, we examined the level of E383A ProA in the ⌬argC::kan ⌬proA::cat strain carrying the structural mutation or both the promoter and structural mutations in pBeloBACII grown on M9/glucose supplemented with Pro. (Strains carrying WT proA or proA with just the promoter mutation cannot grow under these conditions.) The normal GP reductase activity of ProA is not needed under these conditions. Nevertheless, E383A ProA is expressed at a level 12-fold higher than that in cells grown on glucose with Pro and Arg. Cells grown under these conditions should have an impaired ability to synthesize Arg. Because there is unlikely to be a specific mechanism for increasing expression of E383A ProA in response to a need for Arg, a more global and nonspecific mechanism is indicated. Amino acid limitation is known to activate the stringent response, which down-regulates synthesis of tRNA, rRNA and protein, up-regulates protein turnover, and up-regulates amino acid biosynthesis (25, 26) . We suspect that the increase in expression of E383A ProA is attributable to activation of the stringent response.
Interestingly, the promoter mutation increases the growth rate of cells expressing E383A ProA (Fig. 3 A and B) . E383A ProA is overexpressed by 14-fold in cells grown on glucose relative to its expression in cells grown with Pro and Arg. Notably, in cells carrying the promoter mutation, 30% less E383A ProA is present (Fig. 4) . This pattern was also seen when the cells were grown with either Pro or Arg. This seems counterintuitive, since the promoter mutation increases expression of ProA (E383A or WT) by 4-fold in cells grown on glucose with Pro and Arg. However, if overexpression of E383A ProA during growth on glucose is attributable to activation of the stringent response, the drastic shift in physiological state caused by amino acid limitation would be expected to slow growth. The 4-fold increased expression of E383A ProA enabled by the promoter mutation should allow more Pro and Arg to be produced, leading to less severe activation of the stringent response, and, consequently, both a lower overall level of E383A ProA and less slowing of growth. Such an interplay between activation by the stringent response and repression by the presence of a specific amino acid has been shown to occur in the case of starvation for leucine (27) .
Discussion
There is a rich literature addressing the evolutionary potential of promiscuous activities, beginning with the classic studies of Hartl and Hall (28) and Hall (29) on evolved beta-galactosidase, Clarke and Drew (30) on amidases, and Hartley and coworkers (31) on ribitol dehydrogenase in the 1970s. These studies showed that mutations that increase the efficiency of a promiscuous activity or increase expression or copy number of the corresponding gene can allow bacteria to grow on novel carbon/ nitrogen sources. Recently, the evolutionary potential of promiscuous activities has been studied by identifying promiscuous activities in libraries using a screen or selection and then using in vitro evolution methods to enhance the promiscuous activity. Examples of this approach include the identification and evolution of promiscuous sugar kinase activities (32) and the promiscuous phosphoribosylanthranilate isomerase activity of glutamine phosphoribosylpyrophosphate amidotransferase (33) . However, in all these cases, experiments were carried out under conditions in which the original activity of the protein was not required for growth. (Indeed, the normal function of evolved beta-galactosidase has never been identified.) Thus, a significant gap remains in our understanding of how a requirement to maintain the original activity of the protein affects the trajectory for evolution of a promiscuous activity.
The emergence of a physiologically significant activity from a promiscuous activity under conditions in which both activities are essential for growth has not been previously studied. Although a strain lacking argC cannot grow on glucose, a single point mutation in proA restores slow growth. E383A ProA is an unimpressive enzyme; the mutation elevates the very low NAGP reductase activity by only 12-fold, while decreasing the normal GP reductase activity by 2,800-fold. However, the physiological impact of the mutation is amplified by a 14-fold overexpression of the mutant proA, which likely results from activation of the Both activities were assayed in the reverse direction because of the instability of the acyl phosphate substrates. Standard errors are given in parentheses. *Only k cat/KM could be measured, because the enzyme could not be saturated with NAGSA. † Assessed by changes in the intrinsic fluorescence of the protein upon titration with NAGSA or GSA.
stringent response due to insufficient supplies of Pro and Arg. Notably, the ⌬argC::kan ⌬proA::cat strain carrying WT proBA or the version with the promoter mutation cannot grow on glucose. Clearly, both enhancement of NAGP reductase activity and overexpression are required for growth.
When the altered kinetic parameters and overexpression of E383A ProA are taken into account, PR1 cells have 200-fold less GP reductase activity but 170-fold more NAGP reductase activity than the ⌬argC::kan strain. This is still a substantial deficit relative to WT E. coli. However, fluxes through the two pathways in vivo may be higher than expected based upon the kinetic parameters of the enzyme because the inefficiency of E383A ProA should result in accumulation of both GP and NAGP. If the enzyme is not saturated, higher substrate concentrations will increase the flux through this step. Such a situation occurs in E. coli lacking diaminopimelate epimerase (DapF), which converts L,L-diaminopimelate to meso-diaminopimelate in the pathway for synthesis of peptidoglycan. The mutant strain accumulates up to 10 mM L,L-diaminopimelate but is able to produce small amounts of meso-diaminopimelate and normal amounts of some downstream metabolites, suggesting that a promiscuous racemase produces enough meso-diaminopimelate for growth in the presence of a very high substrate concentration (34).
The results described here provide important insights into the evolution of new enzymes. As observed previously, a single point mutation can elevate the level of a promiscuous activity. Even a poor level of activity provides a potential for further mutations to enhance the activity if the cells can survive. The degree to which damage to the original function can be tolerated depends upon the importance of each activity for the fitness of the organism and the extent to which changes in gene expression can compensate for the inefficiency of the new and, in some cases, the original activity. Regulatory changes due to promoter mutations are easily achieved but may not provide sufficient enhancement of the level of activity. In the case described here, a promoter mutation led to only fourfold enhancement of expression, which was insufficient to support growth. However, more significant overexpression was caused by a general physiological response to the inefficiency of the mutant enzyme. Compensatory overexpression of an inefficient bifunctional enzyme has not been recognized as an important force in the evolution of new enzymatic activities during a period of gene sharing. Such overexpression provides an additional dose of the promiscuous activity that that may be essential for survival. Such a situation is ripe for the next stage in evolution of the new enzyme; gene duplication should enhance fitness by increasing the amount of enzyme that can be produced. Subsequently, one copy would be expected to undergo mutations to restore GP reductase activity, most likely by reversion of the mutation leading to the E383A change. The other copy would be freed from constraints due to the need to provide GP reductase activity and could more quickly accumulate mutations leading to efficient NAGP reductase activity. There are likely to be many evolutionary trajectories leading to improved NAGP reductase activity, depending upon both the number of mutations required to improve the activity and the timing of the gene duplication that would relieve constraints imposed by the need for the enzyme to provide two functions. The mutation that leads to the E383A change might persist during optimization of NAGP reductase activity, or additional mutations might result in either reversion to Glu or replacement with a different amino acid as sequence space is explored.
Methods
Strains. E. coli BW25113 ⌬argC::kan (JW39301) was obtained from the Keio collection (19) . The proA was replaced in this strain and in PR1 with the cat gene using the method of Datsenko and Wanner (23).
Materials. N-acetylglutamate 5-semialdehyde (NAGSA) was prepared using N-succinyldiaminopimelate-aminotransferase/acetylornithine transamine (ArgD) from E. coli as described by Vogel and McLellan (20) . Glutamate 5-semialdehyde (GSA) was prepared from NAGSA by acid hydrolysis (2.25 M HCl, 120°C, 30 min). The solution was neutralized with sodium acetate and used immediately.
Chemical Mutagenesis. E. coli BW25113 ⌬argC::kan was subjected to chemical mutagenesis by using MNNG. Cells were rinsed with deionized water and plated on M9/glucose (35) supplemented as described by Neidhardt et al. (36) . In a second experiment, diaminopimelate (0.5 mM), succinate (20 mM), and glycerol (12.5 mM) were added as well to compensate for unanticipated mutations in essential biosynthetic pathways. After incubation at 37°C for 2 weeks, 23 pseudorevertants that could grow on M9/glucose were obtained.
Purification of NAGSA Dehydrogenase Activity from PR1. A 2-liter culture of PR1 was grown in M9/glucose at 37°C for 3 days to OD 595 ϭ 0.6. Cells were harvested by centrifugation and then lysed in 20 mM potassium phosphate, pH 8.0 (Buffer A) containing 1 mg/ml lysozyme and 20 mM EDTA (10 min, 25°C). Debris was removed by centrifugation. The cell extract was dialyzed twice against Buffer A at 4°C. The dialysate was loaded onto a 30-ml QSepharose column. The column was washed with Buffer A, and proteins were eluted using a gradient from 0 to 1 M KCl in 300 ml of Buffer A. Fractions were assayed for NAGSA dehydrogenase activity by following reduction of NADP ϩ in a mixture containing 100 mM sodium glycinate, pH 9.3, 1 mM NADP ϩ , 5 mM NAGSA, and 25 mM potassium phosphate. Fractions containing activity were pooled and dialyzed against Buffer A containing 3 M KCl at 4°C. The dialysate was loaded onto a 10-ml phenyl-Sepharose column. Proteins were eluted using a 100-ml gradient from 3 to 0 M KCl in Buffer A. Fractions containing activity were pooled and exchanged into Buffer A containing 150 mM KCl, using an Amicon ultrafiltration device. The protein was loaded onto a Superdex 200 HR 10/30 column (GE Healthcare). Proteins in the fraction with highest activity were precipitated using 10% trichloroacetic acid. The precipitate was resuspended in loading buffer and subjected to SDS/PAGE. Protein bands were digested in the gel with trypsin according to the Promega protocol (Trypsin Gold, Mass Spectrometry Grade, Technical Bulletin). Electrospray ionization mass spectrometric analysis was carried out using an Agilent 1100 Series LC/MSD Trap XCT. Peptide fragmentation patterns were compared with those predicted for E. coli proteins using Mascot (Matrix Science).
Complementation of the ⌬argC::kan Strain with a Genomic Library from PR1. Genomic DNA was extracted from PR1 using a Qiagen DNeasy Tissue Extraction kit, digested with BamHI and EcoRI, and the fragments were separated by agarose gel electrophoresis. A band containing fragments Ͼ3 kb was excised, and the DNA was extracted by using a QIAGEN Gel Extraction kit. Purified fragments were ligated into pUC18 (Fermentas). Electrocompetent ⌬argC::kan cells were transformed with the purified ligation mixture, rinsed, and plated on M9/glucose agar. After incubation at 37°C for 3 days, colonies were restreaked on fresh plates. One hundred colonies were obtained from ϳ1 ϫ 10 5 transformants. Plasmids isolated from three colonies were used to retransform the ⌬argC::kan strain. Plasmids were prepared from colonies that grew on glucose, and the inserted fragments were sequenced.
Complementation of Growth in the ⌬argC::kan ⌬proA::cat Strain by WT and Mutant proBA. proBA (including the promoter) was amplified from E. coli BW25113 and cloned between the BamHI and SphI sites of pBeloBACII (New England Biolabs). A (cac) 6 was added to the 3Ј end of proA to add a C-terminal His 6-tag to ProA. The promoter mutation (c to t at the Ϫ5 position), structural mutation (a1148c), and both mutations were introduced into pBeloBACII proBA-His 6 by using the QuikChange protocol. The resulting plasmids were introduced into the ⌬argC::kan ⌬proA::cat strain by electroporation. The tag had no effect on the rate of growth on glucose (conditions in which ProA activity limits growth because it supplies NAGP reductase activity), indicating that the tag had little or no effect on enzymatic activity.
Expression and Purification of Enzymes. proA was amplified from E. coli BW25113 ⌬argC::kan and PR1. Polymerase chain reaction fragments were digested with NheI and XhoI and ligated into pTrcHisB. ProA was expressed in the ⌬argC::kan strain or the ⌬argC::kan ⌬proA::cat strain grown in 250 ml of LB containing ampicillin (100 g/ml) at 37°C. Isopropyl ␤-D-thiogalactoside (0.5 mM) was added at mid log phase. After 3 h, cells were harvested by centrifugation. The pellet was resuspended in 20 ml of 50 mM sodium phosphate, pH 8.0 (Buffer B) containing 300 mM NaCl and 10 mM imidazole. Cells were lysed with 1 mg/ml lysozyme. Nucleic acids were degraded with 20 units of Benzonase for 30 min on ice. Debris was removed by centrifugation. The extract was loaded onto a 3-ml Ni-NTA (nickel-nitrotriacetic acid) agarose column. The column was washed with Buffer B containing 300 mM NaCl and 10 mM imidazole and then with Buffer B containing 300 mM NaCl and 20 mM imidazole. Bound proteins were eluted with Buffer B containing 300 mM NaCl and 250 mM imidazole and were exchanged into 20 mM potassium phosphate, pH 7.6, using an Amicon ultrafiltration device (30 kDa) .
N-acetylglutamylphosphate reductase and ArgD (N-succinyldiaminopimelateaminotransferase/acetylornithine transaminase) were prepared from the respective ASKA clones (JW3930 and JW3322) (37) in a similar fashion.
Enzyme Assays. NAGSA and GSA dehydrogenase activities were assayed in 100 mM potassium phosphate, pH 7.6, containing 1 mM NADP ϩ and various concentrations of NAGSA or GSA at 25°C. Activity was measured by monitoring the increase in OD340 due to reduction of NADP ϩ . Protein concentrations were determined using the Bradford assay with BSA as the standard (38) .
Binding of NAGSA and GSA to WT and E383A ProA. Dissociation constants were determined by adding aliquots of NAGSA or GSA to WT or E383A ProA (17.5 M) in 100 mM potassium phosphate, pH 7.6, and monitoring the intrinsic fluorescence of the protein on a Photon Technology International fluorometer. Fluorescence was excited at 282 nm, and emission was monitored at 318 nm. The fluorescence signal was plotted versus total substrate concentration ([S]0) and fit to Eq. 2. The total change in fluorescence (⌬F), initial fluorescence (F0), and dissociation constant (KD) were obtained from each fit.
Western Blots. Cultures of the ⌬argC. kan ⌬proA::cat strain carrying pBeloBA-CII with WT or mutant proBA were grown at 37°C on M9/glucose with and without Pro and/or Arg (1 mM) to an OD600 of 0.6 Ϯ 0.1. Cells were harvested by centrifugation and resuspended in Mg/SDS lysis buffer (39) to an OD600 of 10. Cells were incubated at 120°C for 2 min. Debris was removed by centrifugation. Ten microliters of each lysate was loaded onto a 10% SDS gel. Proteins were subjected to electrophoresis and then transferred onto nitrocellulose overnight. His-tagged proteins were detected by using Penta-His Antibody (Qiagen) and goat anti-mouse-IgG-HRP conjugate (Jackson ImmunoResearch), followed by chemiluminescence assay according to the manufacturer's instructions (Western Lightning, Perkin-Elmer). Concentrations of tagged proteins were estimated by using the ImageJ program (National Institutes of Health).
